>From the New York Times today:
SÃO PAULO, Brazil, Aug. 31 - The Swiss drug giant Roche Holding (news/quote) reached an agreement with Brazilian health authorities today to cut the price of the AIDS drug Viracept by a further 40 percent, putting an end to threats by the government to break the patent and produce the drug locally.
The new discount reduces the price of Viracept in Brazil to about 30 percent of what Roche charges in the United States.
The agreement comes as a relief to the pharmaceutical industry. If Brazil had carried out its threat to ignore Roche's patent on Viracept, drug companies believed, a host of other developing countries might have followed its lead and begun manufacturing patented drugs for AIDS and other diseases. Poor countries have complained loudly that international drug companies charge far more for many medicines than they can afford to pay.